4//SEC Filing
Galante Joseph C 4
Accession 0001209191-23-021278
CIK 0001087294other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:39 PM ET
Size
4.6 KB
Accession
0001209191-23-021278
Insider Transaction Report
Form 4
Galante Joseph C
Director
Transactions
- Award
Common Stock
2023-03-24$1.92/sh+1,000$1,920→ 58,356 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 24, 2024.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001632384
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:39 PM ET
- Size
- 4.6 KB